Colorectal function preservation in posterior and total supralevator exenteration for gynecologic malignancies: an 89-patient series

被引:27
作者
Moutardier, V
Houvenaeghel, G
Lelong, B
Mokart, D
Delpero, JR
机构
[1] Inst J Paoli I Calmettes, F-13009 Marseille, France
[2] Univ Mediterranee, F-13009 Marseille, France
关键词
pelvic exenteration; gynecologic malignancies; diverting stomy; colorectal function;
D O I
10.1016/S0090-8258(03)00069-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. The objective of this study was to analyze our experience with colorectal function preservation at the time of pelvic exenteration. Methods. Between January 1980 and December 2001, 201 pelvic exenterations for gynecologic malignancies were performed in our hospital. Ninety-eight were supralevator exenterations and 89 were selected for this study because low colorectal anastomosis (LCRA) was performed. There were locally advanced or recurrent cancers including 50 cervical, 28 ovarian, 11 endometrial, and 3 vaginal malignancies and 5 pelvic sarcomas. Results. Thirty-nine patients (44%) had a history of previous irradiation. There were were 50 posterior and 39 total exenterations. A diverting stomy and/or pelvic filling were performed respectively in 44 (49.4%) and 26 (29%) cases. The postoperative mortality rate was 4.5% (4/89). Seventeen patients experienced a colorectal anastomotic fistula (AF). AF occurred significantly more frequently in irradiated patients (14/17 = 82%). The mortality rate related to AF was 6% (1/17). Ultimately the functional colorectal anastomosis rate was 71.9%, respectively 61.5 and 80% in irradiated and nonirradiated patients. Conclusions. Colorectal function preservation in supralevator exenteration for gynecologic malignancies can be achieved safely in a majority of patients. In irradiated patients a systematically diverting stomy may result in a low mortality rate. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:155 / 159
页数:5
相关论文
共 12 条
[1]  
BEREK JS, 1984, OBSTET GYNECOL, V64, P715
[2]  
Chi DS, 1999, SEMIN SURG ONCOL, V17, P161, DOI 10.1002/(SICI)1098-2388(199910/11)17:3<161::AID-SSU4>3.0.CO
[3]  
2-I
[4]  
Crowe PJ, 1999, SEMIN SURG ONCOL, V17, P152, DOI 10.1002/(SICI)1098-2388(199910/11)17:3<152::AID-SSU3>3.0.CO
[5]  
2-J
[6]   Improved survival and reduction in local failure rates after preoperative radiotherapy -: Evidence for the generalizability of the results of Swedish Rectal Cancer Trial [J].
Dahlberg, M ;
Glimelius, B ;
Påhlman, L .
ANNALS OF SURGERY, 1999, 229 (04) :493-497
[7]   PELVIC EXENTERATION WITH LOW RECTAL ANASTOMOSIS - SURVIVAL, COMPLICATIONS, AND PROGNOSTIC FACTORS [J].
HATCH, KD ;
GELDER, MS ;
SOONG, SJ ;
BAKER, VV ;
SHINGLETON, HM .
GYNECOLOGIC ONCOLOGY, 1990, 38 (03) :462-467
[8]   COLORECTAL ANASTOMOSIS ON A GYNECOLOGIC ONCOLOGY SERVICE [J].
HOFFMAN, MS ;
LYNCH, CM ;
GLEESON, NC ;
FIORICA, JV ;
ROBERTS, WS ;
CAVANAGH, D .
GYNECOLOGIC ONCOLOGY, 1994, 55 (01) :60-65
[9]   Continent urinary diversion and low-rectal anastomosis in patients undergoing exenterative procedures for recurrent gynecologic malignancies [J].
Husain, A ;
Curtin, J ;
Brown, C ;
Chi, D ;
Hoskins, W ;
Poynor, E ;
Alektiar, K ;
Barakat, R .
GYNECOLOGIC ONCOLOGY, 2000, 78 (02) :208-211
[10]   Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer [J].
Kapiteijn, E ;
Marijnen, CAM ;
Nagtegaal, ID ;
Putter, H ;
Steup, WH ;
Wiggers, T ;
Rutten, HJT ;
Pahlman, L ;
Glimelius, B ;
van Krieken, JHJM ;
Leer, JWH ;
van de Velde, CJH .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (09) :638-646